The Coming Wave of Biosimilar Medications
These alternatives to biologics offer the opportunity for up to $375 billion in savings over the next 10 years
Read MoreExpress Scripts Adds Three Biosimilars to Largest Formulary to Promote Competition and Advance Affordability, Choices for Patients
Read More
Trends in Health Care Point to a Health Care Delivery Transformation
Addressing rising costs of care and enabling better health outcomes are just a few of the reasons that plan sponsors should think of providing alternative options for care access. This topic was th...
Read MoreMeet Joan Harvey, President, Evernorth Care Solutions
Harvey talks about her career, how her dad’s restaurant molded her into the professional she is today, and what it’s like being a woman in the business world.
Read MoreGame changer: Three things to know about interchangeable biosimilars
The first interchangeable biosimilar is now available. Here’s what plans need to know about these products, which – like generics – can be substituted at the pharmacy.
Read MoreUnderstanding Hemophilia
Breaking down the challenges, therapies and costs associated with hemophilia.
Read MoreEvernorth Enters Strategic Collaboration with VillageMD to Accelerate Value-Based Services and Care Delivery Strategy
Read More
Why a home infusion strategy is more important than ever
Growing demand and new regulations have put the onus on plan sponsors to prioritize the need for a comprehensive home infusion strategy.
Read MoreExperts at Evernorth Outcomes event stress the importance of an integrated data model to improve health and lower costs
During the closing session of the Evernorth Outcomes client event, panelists discussed the power of integrating pharmacy, medical, and behavioral care and looked ahead to explore the biggest opportuni...
Read MoreHow Value-based Solutions Can Improve Costs and Health Outcomes for Chronic Conditions
Over 125 million Americans suffer from chronic conditions, costing the U.S. over $3.4 trillion annually. This topic was the focus of a breakout session at Outcomes+ 2022.
Read More